Predictive factors for the development of brain metastases in patients with malignant melanoma: a study by the Anatolian society of medical oncology

Gumusay, Ozge; Coskun, UĞUR; Akman, Tulay; Ekinci, Ahmet; Kocar, Muharrem; Erceleb, Ozlem; Yazici, OZAN; Kaplan, Mehmet; Berk, Veli; Cetin, Bulent; Taskoylu, Burcu; Yildiz, Ayhan; Goksel, Gamze; ALACACIOĞLU, AHMET; Demirci, Umut; Algin, Efnan; UYSAL, MÜKREMİN; Oztop, Ilhan; Oksuzoglu, Berna; Dane, Faysal; Gumus, Mahmut; Buyukberber, Suleyman

doi:10.1007/s00432-013-1553-7

Predictive factors for the development of brain metastases in patients with malignant melanoma: a study by the Anatolian society of medical oncology

Atıf İçin Kopyala

Gumusay O., Coskun U., Akman T., Ekinci A. S., Kocar M., Erceleb O. B., ...Daha Fazla

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, cilt.140, sa.1, ss.151-157, 2014 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 140 Sayı: 1
Basım Tarihi: 2014
Doi Numarası: 10.1007/s00432-013-1553-7
Dergi Adı: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.151-157
Anahtar Kelimeler: Melanoma, Brain metastases, Predictive factors, CENTRAL-NERVOUS-SYSTEM, CEREBRAL METASTASES, CUTANEOUS MELANOMA, PROGNOSTIC-FACTORS, THERAPY, SURVIVAL, LYMPHADENECTOMY, FEATURES, TRIAL, STAGE
Gazi Üniversitesi Adresli: Evet

Özet

The development of brain metastases (BMs) was associated with poor prognosis in melanoma patients. Patients with BMs have a median survival of < 6 months. Melanoma is the third most common tumor to metastasize to the brain with a reported incidence of 10-40 %. Our aim was to identify factors predicting development of BMs and survival.